Clinical Trials Browser

Phase 3 × Unknown × Cardiotoxicity × Clear all

NCT05728632 2023-02-23

CONTROL

Phase 3 Unknown

Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse, Ventricular Dysfunction, Left, Cardiotoxicity

NCT02236806 2022-02-01

SAFE

Phase 3 Unknown

Breast Neoplasms, Cardiotoxicity

NCT04030546 2019-12-18

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Phase 3 Unknown

Heart Failure, Cardiotoxicity